Nephros (NEPH) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.36% |
| Dec 31, 2025 | -43.11% |
| Sep 30, 2025 | 15.45% |
| Jun 30, 2025 | 20.94% |
| Mar 31, 2025 | -41.78% |
| Dec 31, 2024 | 33.35% |
| Sep 30, 2024 | -6.39% |
| Jun 30, 2024 | -22.06% |
| Mar 31, 2024 | 7.04% |
| Dec 31, 2023 | -24.24% |
| Sep 30, 2023 | -21.10% |
| Jun 30, 2023 | -33.11% |
| Mar 31, 2023 | 20.47% |
| Dec 31, 2022 | -16.54% |
| Sep 30, 2022 | -9.76% |
| Jun 30, 2022 | -19.63% |
| Mar 31, 2022 | -37.62% |
| Dec 31, 2021 | 6.76% |
| Sep 30, 2021 | -3.10% |
| Jun 30, 2021 | -33.86% |
| Mar 31, 2021 | 31.75% |
| Dec 31, 2020 | 50.05% |
| Sep 30, 2020 | -34.82% |
| Jun 30, 2020 | -35.23% |
| Mar 31, 2020 | 48.57% |
| Dec 31, 2019 | 5.36% |
| Sep 30, 2019 | -20.65% |
| Jun 30, 2019 | 37.25% |
| Mar 31, 2019 | -56.03% |
| Dec 31, 2018 | -9.77% |
| Sep 30, 2018 | 74.89% |
| Jun 30, 2018 | 100.99% |
| Mar 31, 2018 | -31.21% |
| Dec 31, 2017 | 50.81% |
| Sep 30, 2017 | 24.76% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | 1.46% |
| Dec 31, 2016 | -3.53% |
| Sep 30, 2016 | -31.58% |
| Jun 30, 2016 | 29.69% |
| Mar 31, 2016 | -17.85% |
| Dec 31, 2015 | -25.78% |
| Sep 30, 2015 | 58.16% |